X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA UNICHEM LAB AJANTA PHARMA/
UNICHEM LAB
 
P/E (TTM) x 21.1 22.6 93.4% View Chart
P/BV x 9.1 2.4 383.6% View Chart
Dividend Yield % 0.7 0.8 82.4%  

Financials

 AJANTA PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
UNICHEM LAB
Mar-16
AJANTA PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,720334 515.0%   
Low Rs1,103174 633.9%   
Sales per share (Unadj.) Rs194.6146.9 132.5%  
Earnings per share (Unadj.) Rs45.211.9 380.2%  
Cash flow per share (Unadj.) Rs50.316.2 310.7%  
Dividends per share (Unadj.) Rs8.002.00 400.0%  
Dividend yield (eoy) %0.60.8 72.0%  
Book value per share (Unadj.) Rs132.0105.1 125.6%  
Shares outstanding (eoy) m88.7790.84 97.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x7.31.7 419.5%   
Avg P/E ratio x31.221.4 146.2%  
P/CF ratio (eoy) x28.115.7 178.8%  
Price / Book Value ratio x10.72.4 442.4%  
Dividend payout %17.716.8 105.2%   
Avg Mkt Cap Rs m125,29923,073 543.0%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m2,5702,558 100.5%   
Avg. sales/employee Rs ThNM2,352.5-  
Avg. wages/employee Rs ThNM450.9-  
Avg. net profit/employee Rs ThNM190.4-  
INCOME DATA
Net Sales Rs m17,27513,346 129.4%  
Other income Rs m166192 86.7%   
Total revenues Rs m17,44213,538 128.8%   
Gross profit Rs m5,8071,639 354.3%  
Depreciation Rs m451390 115.5%   
Interest Rs m4929 169.8%   
Profit before tax Rs m5,4741,412 387.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m1,460293 498.8%   
Profit after tax Rs m4,0141,080 371.5%  
Gross profit margin %33.612.3 273.7%  
Effective tax rate %26.720.7 128.7%   
Net profit margin %23.28.1 287.0%  
BALANCE SHEET DATA
Current assets Rs m7,6395,979 127.8%   
Current liabilities Rs m2,7152,432 111.6%   
Net working cap to sales %28.526.6 107.2%  
Current ratio x2.82.5 114.4%  
Inventory Days Days4363 68.5%  
Debtors Days Days7960 130.3%  
Net fixed assets Rs m6,9146,403 108.0%   
Share capital Rs m177182 97.4%   
"Free" reserves Rs m11,4429,293 123.1%   
Net worth Rs m11,7219,548 122.7%   
Long term debt Rs m149230 64.5%   
Total assets Rs m14,81412,843 115.3%  
Interest coverage x112.950.0 225.7%   
Debt to equity ratio x00 52.6%  
Sales to assets ratio x1.21.0 112.2%   
Return on assets %27.48.6 317.6%  
Return on equity %34.211.3 302.7%  
Return on capital %46.514.3 324.6%  
Exports to sales %55.129.2 188.7%   
Imports to sales %6.06.3 94.7%   
Exports (fob) Rs m9,5273,900 244.3%   
Imports (cif) Rs m1,038847 122.5%   
Fx inflow Rs m10,4224,356 239.2%   
Fx outflow Rs m1,6781,162 144.4%   
Net fx Rs m8,7443,194 273.7%   
CASH FLOW
From Operations Rs m3,2641,119 291.6%  
From Investments Rs m-2,093-853 245.3%  
From Financial Activity Rs m-1,186-334 354.8%  
Net Cashflow Rs m-15-68 21.7%  

Share Holding

Indian Promoters % 73.8 50.1 147.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 15.1 10.3%  
FIIs % 7.6 3.0 253.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 31.7 53.6%  
Shareholders   20,968 20,176 103.9%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   WYETH LTD  PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  SUN PHARMA  CIPLA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 17, 2017 03:13 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS